U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H13Cl3F3N5O3
Molecular Weight 546.714
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tamuzimod

SMILES

FC(F)(F)C1=CN2C=C(N=C2C(Cl)=C1)C3=NC(=NO3)C4=C(Cl)C=C(O[C@@H]5CCC(=O)NC5)C(Cl)=C4

InChI

InChIKey=HNRWGYDMTRPLCQ-SNVBAGLBSA-N
InChI=1S/C21H13Cl3F3N5O3/c22-12-5-16(34-10-1-2-17(33)28-6-10)13(23)4-11(12)18-30-20(35-31-18)15-8-32-7-9(21(25,26)27)3-14(24)19(32)29-15/h3-5,7-8,10H,1-2,6H2,(H,28,33)/t10-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Tamuzimod
INN  
Official Name English
(5R)-5-(2,5-dichloro-4-{5-[8-chloro-6- (trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4- oxadiazol-3-yl}phenoxy)piperidin-2-one
Systematic Name English
(5R)-5-(2,5-dichloro-4-{5-[8-chloro-6- (trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4- oxadiazol-3-yl}phenoxy)piperidin-2-one
Systematic Name English
tamuzimod [INN]
Common Name English
Code System Code Type Description
FDA UNII
K02SHW3KV9
Created by admin on Sat Dec 16 14:17:28 GMT 2023 , Edited by admin on Sat Dec 16 14:17:28 GMT 2023
PRIMARY
CAS
2097854-81-2
Created by admin on Sat Dec 16 14:17:28 GMT 2023 , Edited by admin on Sat Dec 16 14:17:28 GMT 2023
PRIMARY
INN
12504
Created by admin on Sat Dec 16 14:17:28 GMT 2023 , Edited by admin on Sat Dec 16 14:17:28 GMT 2023
PRIMARY
PUBCHEM
129143185
Created by admin on Sat Dec 16 14:17:28 GMT 2023 , Edited by admin on Sat Dec 16 14:17:28 GMT 2023
PRIMARY
NCI_THESAURUS
C199116
Created by admin on Sat Dec 16 14:17:28 GMT 2023 , Edited by admin on Sat Dec 16 14:17:28 GMT 2023
PRIMARY